Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:29 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 3,579 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Cardiac Event
Interventions: Retia Non-Invasive Sensors; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Spinal Cord Injury, Hypogonadism
Interventions: Testosterone Transdermal System (Androderm 5 mg patch); Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2012
U.S. locations: 2
States / cities: West Orange, New Jersey • The Bronx, New York

Conditions: Pancreatic Cancer, Pancreatic Cyst
Interventions: Blood Sample collection, Tissue sample collection, Data collection; Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 1,274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Lakewood Rch, Florida • Miami, Florida • Tampa, Florida

Conditions: Pruritus, Atopic Dermatitis
Interventions: difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream, Placebo, Vehicle Cream; Drug
Lead sponsor: Cara Therapeutics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 61
States / cities: Scottsdale, Arizona • Fort Smith, Arkansas • Rogers, Arkansas + 56 more

Conditions: UGI Bleeding, Ulcer or Variceal Hemorrhage, Stigmata of Recent Hemorrhage, Endoscopy, Randomized Controlled Trials
Interventions: Doppler endoscopic ultrasound probe for blood flow detection, Standard endoscopic hemostasis; Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 2
States / cities: Los Angeles, California • West Los Angeles, California

Conditions: Lung Tumor, Lung Cancer
Interventions: Microdevice loaded with 19 chemotherapeutic agents; Combination Product
Lead sponsor: Oliver Jonas; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Relapsing Multiple Sclerosis
Interventions: Remibrutinib oral treatment, Ocrelizumab; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 45
States / cities: Scottsdale, Arizona • Irvine, California • Washington D.C., District of Columbia + 40 more

Conditions: Grade II Glioma, Grade III Glioma, Grade IV Glioma, Astrocytoma, Oligodendroglioma of Brain, Anaplastic Astrocytoma of Brain, Anaplastic Oligodendroglioma, Glioblastoma
Interventions: Microdevice; Combination Product
Lead sponsor: Oliver Jonas; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Amblyopia
Interventions: IO-therapy Glasses, patch; Device
Lead sponsor: Salus University; Other
Eligibility: 3 Years to 8 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Elkins Park, Pennsylvania

Conditions: Pain
Interventions: Fentanyl Transdermal Matrix Patch ZR-02-01; Drug
Lead sponsor: ZARS Pharma Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 6
States / cities: Phoenix, Arizona • Loma Linda, California • Marietta, Georgia + 3 more

Conditions: Glioma, Brain Neoplasms
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Oral Leukoplakia
Interventions: Pioglitazone hydrochloride, placebo, laboratory biomarker analysis; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 11
States / cities: Birmingham, Alabama • Iowa City, Iowa • Boston, Massachusetts + 6 more

Conditions: Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple
Interventions: ICG Intervention, Near Infrared Camera; Drug · Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Renal Artery Stenosis, Hypertension, Renovascular
Interventions: iCAST™ Rx Stent System; Device
Lead sponsor: Atrium Medical Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 12
States / cities: Fremont, California • Loveland, Colorado • Clearwater, Florida + 9 more

Conditions: Critical Limb Ischemia
Interventions: Drug Eluting Stent - Below the Knee, Standard PTA Control Arm; Combination Product · Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 26
States / cities: Jonesboro, Arkansas • Little Rock, Arkansas • San Francisco, California + 21 more

Conditions: Spinal Cord Injury
Interventions: Resistance Training and Testosterone Patches, Testosterone Patches; Device · Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Menopause
Interventions: estrogen patch, Amino acids, Placebo Patch, Placebo pills; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 48 Years to 60 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Smoking Cessation
Interventions: Distress Tolerance Treatment for Weight Concern (DT-W), Health Education (HE), Smoking Cessation counseling, Transdermal Nicotine Patch; Behavioral · Drug
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Carotid Artery Diseases, Aortic Diseases, Peripheral Arterial Diseases
Interventions: Intergard Standard - Collagen Coated Vascular Grafts and Patches, Hemashield - Collagen Coated Vascular Grafts and Patches, Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches, Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts; Device
Lead sponsor: Intervascular; Industry
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Hershey, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Postherpetic Neuralgia
Interventions: Civamide Patch; Drug
Lead sponsor: Winston Laboratories; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 3
States / cities: Sunrise, Florida • Chicago, Illinois • Ann Arbor, Michigan

Conditions: Cigarette Smoking, Smoking Cessation, Depression
Interventions: Treatment as Usual, Goal2Quit + NRT Sampling; Behavioral · Combination Product
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Human Immunodeficiency Virus, Smoking Cessation, Smoking, Cigarette, Smoking, Anxiety, Depression, Nicotine Dependence
Interventions: QUIT, Time-Matched Control (TM); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 79 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 3
States / cities: Boston, Massachusetts • Houston, Texas

Conditions: Cystic Pancreatic Disorders
Interventions: Not listed
Lead sponsor: Somashekar Krishna; Other
Eligibility: 18 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Peripheral Arterial Disease
Interventions: Not listed
Lead sponsor: TriReme Medical, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 13
States / cities: Phoenix, Arizona • Rancho Mirage, California • Gainesville, Florida + 9 more

Search by objective public record fields.

Minimally Invasive Cardiac Output Monitoring Device

Testosterone Replacement Therapy in Chronic Spinal Cord Injury

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Doppler Ultrasound Probe for Blood Flow Detection in Severe Upper Gastrointestinal Hemorrhage

Microdevice for Evaluating Drug Response in Site in Lung Lesions

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Implantable Microdevice In Primary Brain Tumors

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy

Pioglitazone for Oral Premalignant Lesions

Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions

Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Resistance Training and Testosterone After Spinal Cord Injury

Estrogen and Serotonin on Changing Brain Chemistry

Women Engaging in Quitting Smoking Together

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia

Goal2Quit + NRT Sampling

Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV

Comparison of CLE in Vivo Diagnosis and ex Vivo Examination Against Surgical Histopathology of CPL

Chocolate Balloon Angioplasty Registry